Related Experiment Video
Updated: May 27, 2026
11:36
Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs
Published on: April 21, 2012
Leishmaniasis.
1Inflammation Division, Walter+Eliza Hall Institute of Medical Research, Department of Medical Biology, The University of Melbourne, Parkville, Australia. kedzierski@wehi.edu.au
Human Vaccines
|November 4, 2011
Summary
Developing a leishmaniasis vaccine is crucial for global health, yet challenges remain in translating lab findings to effective field use. Overcoming these hurdles is key to controlling this widespread parasitic disease.
Area of Science:
- Medical Research
- Parasitology
- Vaccinology
Background:
- Leishmaniasis presents a spectrum of illness, from skin lesions to fatal systemic infections.
- The World Health Organization (WHO) designates leishmaniasis as an emerging, uncontrolled disease, with 2 million new cases annually.
- Globally, 12 million individuals are infected, and 350 million are at risk across 88 countries.
Purpose of the Study:
- To review recent advancements in antileishmanial vaccine development.
- To identify and discuss the primary obstacles hindering the implementation of leishmaniasis vaccines.
Main Methods:
- This review synthesizes current research findings in the field of antileishmanial vaccines.
- It analyzes the challenges associated with transitioning vaccine candidates from laboratory settings to real-world applications.
- The review also examines difficulties in extrapolating data from animal models to human efficacy.
Main Results:
- Despite significant research efforts, no universally effective leishmaniasis vaccine is currently available.
- A major impediment is the difficulty in validating vaccine efficacy and safety across diverse populations and environments.
- Translating preclinical data to successful clinical outcomes remains a significant challenge.
Conclusions:
- Vaccination is the most promising strategy for controlling all forms of leishmaniasis.
- The development of a safe, effective, and affordable antileishmanial vaccine is a critical global public health priority.
- Addressing the challenges in preclinical-to-clinical translation is essential for achieving vaccine implementation.
Related Concept Videos
01:30Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
01:22American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
01:26Rocky Mountain Spotted Fever
Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
01:28Toxoplasmosis
Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
01:28Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...